SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-013114 to SeaStar Medical Holding Corp (ICU)

SeaStar Medical Holding Corp
Date: Nov. 26, 2024 · CIK: 0001831868 · Accession: 0000000000-24-013114

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-39927

Date
November 26, 2024
Author
David Green
Form
UPLOAD
Company
SeaStar Medical Holding Corp

Letter

November 26, 2024 David Green Chief Financial Officer SeaStar Medical Holding Corp 3513 Brighton Blvd., Suite 410 Denver, CO 80216 Re:SeaStar Medical Holding Corp Form 10-K filed April 16, 2024 File No. 001-39927 Dear David Green: We have reviewed your filing and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Form 10-K for the Fiscal Year Ended December 31, 2023 Item 9A. Controls and Procedures. Management's Annual Report on Internal Control Over Financial Reporting, page 141 1.We note your statement that you are excluding management’s report on internal control over financial reporting pursuant to Section 215.02 of the SEC Division of Corporation Finance’s Regulation S-K Compliance & Disclosure Interpretations. Please note that your facts do not fit within the circumstances set forth in this guidance. Ensure your future filings on Form 10-K include management’s annual report on internal control over financial reporting, as required by Item 308 of Regulation S-K. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeanne Baker at 202-551-3691 or Terence O'Brien at 202-551-3355 if you have questions regarding comments on the financial statements and related matters.

November 26, 2024 Page 2 Sincerely, Division of Corporation Finance Office of Industrial Applications and Services

Show Raw Text
November 26, 2024
David Green
Chief Financial Officer
SeaStar Medical Holding Corp
3513 Brighton Blvd., Suite 410
Denver, CO 80216
Re:SeaStar Medical Holding Corp
Form 10-K filed April 16, 2024
File No. 001-39927
Dear David Green:
            We have reviewed your filing and have the following comment.
            Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
            After reviewing your response to this letter, we may have additional comments.
Form 10-K for the Fiscal Year Ended December 31, 2023
Item 9A. Controls and Procedures.
Management's Annual Report on Internal Control Over Financial Reporting, page 141
1.We note your statement that you are excluding management’s report on internal
control over financial reporting pursuant to Section 215.02 of the SEC Division of
Corporation Finance’s Regulation S-K Compliance & Disclosure Interpretations.
Please note that your facts do not fit within the circumstances set forth in this
guidance. Ensure your future filings on Form 10-K include management’s annual
report on internal control over financial reporting, as required by Item 308 of
Regulation S-K.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence
of action by the staff.
            Please contact Jeanne Baker at 202-551-3691 or Terence O'Brien at 202-551-3355 if
you have questions regarding comments on the financial statements and related matters.

November 26, 2024
Page 2
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services